A database of FDA approved therapeutic peptides and proteins
ID | ThPPID | Name | Peptide Sequence | Length | Functional Classification | Disease | Brand | Company | Physical Appearance | Route of Administartion | Category | Target |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1475 | Th1095 | Ranibizumab | Light Chain SASQDISN Full view | 447 | IIa | Hematological/Eye Disorder | Lucentis | Genentech | Sterile, colorless to pale yellow solution | Intravitreal injection | Ophthalmics | Vascular endothelial growth factor A |
1529 | Th1108 | Pegaptanib | N.A. Full view | 0 | IIa | Hematological/Eye Disorder | Macugen | Gilead Sciences | Sterile, aqueous solution containing pegaptanib sodium for intravitreous injection | Intravitreal injection | Intended for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS. | N.A. |
1615 | Th1133 | Aflibercept | SDTGRPFVEMYSEIPEIIHM Full view | 431 | Ib | Cancer | Eylea | Regeneron Pharmaceuticals | Sterile, clear, and colorless to pale yellow solution. | Intravitreal injection | Antineoplastic Agents and Ophthalmics | Vascular endothelial growth factor A,Placenta growth factor,Vascular endothelial growth factor B |
1622 | Th1135 | Ocriplasmin | Truncated heavy chai Full view | 251 | Ic | Eye Disorder | Jetrea | ThromboGenics NV | Sterile, clear and colorless solution with no preservatives | Intravitreal injection | Ophthalmics | Fibronectin,Alpha-2-macroglobulin,Alpha-2-antiplasmin |